Download PDF
Arzneimittelforschung 2010; 60(10): 593-598
DOI: 10.1055/s-0031-1296331
CNS-active Drugs · Hypnotics · Psychotropics · Sedatives
Editio Cantor Verlag Aulendorf (Germany)

Synthesis and anticonvulsant activity of some alkanamide derivatives

Ayse H. Tarikogullari
1   Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Bornova, Izmir, Turkey
,
Sultan Kilic Fatma
2   Department of Pharmacology, Faculty of Medicine, Osmangazi University, Eskisehir, Turkey
,
Kevser Erol
2   Department of Pharmacology, Faculty of Medicine, Osmangazi University, Eskisehir, Turkey
,
Varol Pabuccuoglu
1   Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Bornova, Izmir, Turkey
› Author Affiliations
Further Information

Publication History

Publication Date:
03 December 2011 (online)

   Permissions and Reprints

Abstract

A group of JV-phenylacetamide, N-phenylpropanamide and N-benzylamide derivatives bearing 5-membered heterocyclic rings such as pyrazole, 1, 2, 4-triazole and imidazole rings at ω position were synthesized and their anticonvulsant activity was evaluated in the maximal electroshock test. The results indicated that the 1, 2, 4-triazole ring leads to superior activity than the pyrazole ring and inserting a CH2 group into the anilide structure leading to N-benzyl derivatives did not change the anticonvulsant activity, but caused a noticeable decrease in duration of action. The most active compound was 2-(lH-l, 2, 4-triazole-l-yl)-N-(2, 6-dimethylphenyl) acetamide.

Key words

Alkanamide - Anilide - Anticonvulsant drugs - Imidazole - Pyrazole - Triazole
 

  • References

  • 1 Lin Z, Kabada PK. Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med Res Rev. 1997; 17 (6) 537-72
    CrossrefPubMedSearch in Google Scholar
  • 2 Löscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol. 1998; 342: 1-13
    CrossrefPubMedSearch in Google Scholar
  • 3 Brodie MJ. Do we need any more new antiepileptic drugs?. Epilepsy Res. 2001; 45: 3-6
    CrossrefPubMedSearch in Google Scholar
  • 4 Malawska B. New anticonvulsant agents. Curr Top Med Chem. 2005; 5: 69-85
    CrossrefPubMedSearch in Google Scholar
  • 5 Deckers CLP, Genton P, Sills GJ, Schmidt D. Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res. 2003; 53: 1-17
    CrossrefPubMedSearch in Google Scholar
  • 6 Kwan P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther. 2001; 90: 21-34
    CrossrefPubMedSearch in Google Scholar
  • 7 Böhme I, Lüddens H. The inhibitory neural circuitry as target of antiepileptic drugs. Curr Med Chem. 2001; 8: 1257-74
    CrossrefPubMedSearch in Google Scholar
  • 8 Clark CR, Wells MJM, Sansom RT, Norris GN, Dockens RC, Ravis WR. Anticonvulsant activity of 4-aminobenzamides. J Med Chem. 1984; 27: 779-82
    CrossrefPubMedSearch in Google Scholar
  • 9 Clark CR, Sansom RT, Lin CM, Norris GN. Anticonvulsant activity of some 4-aminobenzanilides. J Med Chem. 1985; 28: 1259-62
    CrossrefPubMedSearch in Google Scholar
  • 10 Clark CR, Lin CM, Sansom RT. Anticonvulsant activity of 2-and 3-aminobenzanilides. /Med Chem. 1986; 29: 1534-7
    PubMedSearch in Google Scholar
  • 11 Clark CR, Davenport TW. Synthesis and anticonvulsant activity of analogues of 4-amino-iV-(l-phenylethyl)benza-mide. J Med Chem. 1987; 30: 1214-8
    CrossrefPubMedSearch in Google Scholar
  • 12 Clark CR. Comparative anticonvulsant activity and neurotoxicity of 4-amino-iV-(2, 6-dimethylphenyl)benzamide and prototype antiepileptic drugs in mice and rats. Epilepsia. 1988; 29 (2) 198-203
    CrossrefPubMedSearch in Google Scholar
  • 13 Bailleux V, Vallée L, Nuyts JP, Vamecq J. Anticonvulsant activity of some 4-amino-iV-phenylphthalimides and N-(3-amino-2-methylphenyl)phthalimides. Biomed Pharmacother. 1994; 48: 95-101
    CrossrefPubMedSearch in Google Scholar
  • 14 Bailleux V, Vallée L, Nuyts JP, Vamecq J. Synthesis and anticonvulsant activity of some N-phenylphthalimides. Chem Pharm Bull. 1994; 42 (9) 1817-21
    CrossrefPubMedSearch in Google Scholar
  • 15 Bailleux V, Vallée L, Nuyts JP, Hamoir G, Poupaert JH, Stables JP et al. Synthesis and anticonvulsant activity of some 4-nitro-iV-phenylbenzamides. Eur J Med Chem. 1995; 30: 439-444
    CrossrefPubMedSearch in Google Scholar
  • 16 Diouf O, Bourhim M, Lambert DM, Poupaert JH, Stables JP, Vamecq J. Anticonvulsant and neorotoxicological properties of 4-amino-iV-(2-ethylphenyl)benzamide, a potent ameltolide analogue. Biomed Pharmacother. 1997; 51: 131-6
    CrossrefPubMedSearch in Google Scholar
  • 17 Ho B, Venkatarangan PM, Cruse SF, Hinko CN, Andersen PH, Crider AM et al. Synthesis of 2-piperidinecarboxylic acid derivatives as potential anticonvulsants. Eur J Med Chem. 1998; 33: 23-31
    CrossrefPubMedSearch in Google Scholar
  • 18 Soyer Z, Kiliç FS, Erol K, Pabuçcuoglu V. Synthesis and anticonvulsant activity of some ω-(lH-imidazol-l-yl)-N-phenylacetamide and propionamide derivatives. Il Farmaco.. 2003; 59: 595-600
    PubMedSearch in Google Scholar
  • 19 Soyer Z, Kiliç FS, Erol K, Pabuçcuoglu V. The synthesis and anticonvulsant activity of some ω-phthalimido-N-phenylacetamide and propionamide derivatives.. Arch Pharm Pharm Med Chem. 2004; 337: 105-11
    CrossrefPubMedSearch in Google Scholar
  • 20 Gangi FED. Synthesis of some beta-dialkylaminopropio-anilides. J Am Chem Soc. 1955; XLIV: 135-7
    PubMedSearch in Google Scholar
  • 21 Liu S, Pietryka J, Ellars CE, Edwards DS. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for 90Y- and 111In-labeled DOTA-biomolecule conjugates. Bioconjugate Chem. 2002; 13: 902-13
    CrossrefPubMedSearch in Google Scholar
  • 22 Ucar H, Derpoorten KV, Cacciaguerra S, Spampinato S, Stables JP, Depovere P et al. Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazo-lone derivatives. J Med Chem. 1998; 41: 1138-45
    CrossrefPubMedSearch in Google Scholar
  • 23 Özkanh F, Dalkara S, Çalış Ü, Willke A. Synthesis of some N-arylazole acetamide derivatives and their anticonvulsant and antimicrobial activities. Arzneimittelforschung. 1994; 44 (2) 920-4
    PubMedSearch in Google Scholar
  • 24 lovu M, Zalaru C, Dumitrascu F, Draghici C, Cristea E. New substituted 2-(pyrazol-l-yl) o-, m-, p-methylacetanilides with potential local anesthesic and antiarrhythmic action. Part I. Il Farmaco. 2000; 55: 362-8
    CrossrefPubMedSearch in Google Scholar
  • 25 lovu M, Zalaru C, Dumitrascu F, Draghici C, Moraru M, Cristea E. New substituted 2-(pyrazol-l-yl)-dialkylacetani-lides with potential local anesthesic and antiarrhythmic action. Part II. Il Farmaco. 2003; 58: 301-7
    CrossrefPubMedSearch in Google Scholar
  • 26 Dobosz M, Pachuta-Stec A. Synthesis of 1- and 4-ß-acetyl-aminoethyl derivatives of 1, 2, 4-triazole. Acta Pol Pharm. 1993; 50 (4–5) 369-72
    PubMedSearch in Google Scholar
  • 27 Pandey J, Tiwari VK, Verma SS, Chaturvedi V, Bhatnagar S, Sinha S et al. Synthesis and antitubercular screening of imidazole derivatives. Eur J Med Chem. 2009; 44: 3350-5
    CrossrefPubMedSearch in Google Scholar
  • 28 Stables JP, Kupferberg HJ. The NIH anticonvulsant drug development (ADD) program: preclinical anticonvulsant screening project. In: Avanzini G, Regesta G, Tanganelli P, Avoli M. editors Molecular and Cellular Targets for Antiepileptic Drugs. London John Libbey & Co; 1997: 191-198
    Search in Google Scholar